⏳ Fetching live dividend data...
Home › Calculator › WINT Dividend Calculator 2026
Windtree Therapeutics, Inc. · OTC
Price: $0.01 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in WINT → $3.0713115715408475e+33M in 10 years · $255,941,031,330,291,500,000,000,000,000,000,000,000.00/month
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open WINT position with:
Real after-tax yield depends on where you live and how you hold WINT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 15625.00% | 15622.20% | $1,562,500 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 13281.25% | 13278.45% | $1,328,125 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 12500.00% | 12497.20% | $1,250,000 / yr |
| 🇬🇧 UK ISA | 0% | 15625.00% | 15622.20% | $1,562,500 / yr |
| 🇬🇧 UK Taxable | 8.75% | 14257.81% | 14255.01% | $1,425,781 / yr |
| 🇨🇦 TFSA | 0% | 15625.00% | 15622.20% | $1,562,500 / yr |
| 🇨🇦 CA Taxable | 25% | 11718.75% | 11715.95% | $1,171,875 / yr |
| 🇦🇺 Super (pension) | 15% | 13281.25% | 13278.45% | $1,328,125 / yr |
| 🇦🇺 AU Taxable | 30% | 10937.50% | 10934.70% | $1,093,750 / yr |
| 🇩🇪 DE Taxable | 26.375% | 11503.91% | 11501.11% | $1,150,391 / yr |
| 🇫🇷 FR Taxable | 30% | 10937.50% | 10934.70% | $1,093,750 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
WINT pays quarterly — 4 times per year. Next ex-div: TBD.
How WINT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for WINT sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2024-10-08 | 5,431 | $0.91 | $4.9K | ||
| A-Award | 2024-07-22 | 2,674 | $4.11 | $11.0K | ||
| A-Award | 2024-07-22 | 13 | — | — | ||
| A-Award | 2024-07-22 | 4,011 | $4.11 | $16.5K | ||
| A-Award | 2024-07-22 | 19 | — | — | ||
| Buy | 2023-09-27 | 2,500 | $1.02 | $2.5K | ||
| Buy | 2023-09-26 | 2,500 | $0.90 | $2.3K | ||
| Other | 2023-08-24 | 372 | $51.00 | $19.0K | ||
| Other | 2023-08-24 | 200 | $592.50 | $118.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the WINT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →